8-K: Quantum-Si Secures New San Diego Facility Lease
Material Definitive Agreement
Quantum-Si Incorporated has entered into a 10-year lease agreement for a new 54,374 square foot office, laboratory, and manufacturing facility in San Diego, California.
Summary
- Quantum-Si entered into a lease agreement for 54,374 square feet of space at 9955 Pacific Heights Boulevard, San Diego, CA.
- The lease term is 120 months, with an anticipated commencement date of September 1, 2027, and an expiration date of August 31, 2037.
- The agreement includes a 20-month base rent abatement period starting from the commencement date.
- The landlord will provide a tenant improvement allowance of up to $17,127,810 ($315.00 per square foot).
- The company will receive a monthly reimbursement of up to $175,000 for its existing lease obligation through December 31, 2027.
- Initial monthly base rent is approximately $315,369.20, with a 3% annual increase.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral-to-positive strategic development, as it secures necessary infrastructure for future growth while managing cash flow through rent abatements and landlord-funded improvements.
Positives
- Significant tenant improvement allowance of $17.1 million covers the anticipated cost of improvements.
- 20-month base rent abatement provides substantial cash flow relief during the initial phase of the lease.
- Landlord will provide up to $175,000 per month to offset existing lease obligations until December 31, 2027.
- The facility supports the company's Proteus platform development and manufacturing expansion.
Negatives
- The company is committing to a long-term financial obligation of 10 years with annual rent escalations of 3%.
- Requires a significant security deposit in the form of a letter of credit for $2,085,786.64.
- The company is responsible for triple net (NNN) expenses, including taxes and operating expenses.
Risks
- Potential for construction delays regarding tenant improvements, though the lease includes provisions for Landlord Delays.
- Exposure to future operating expense increases, subject to a 5% annual cap on controllable expenses.
- Reliance on the landlord's ability to provide the tenant improvement allowance, secured by a letter of credit from the landlord.
- The company remains liable for its existing lease obligation until its expiration in 2027.
Future Outlook
The company plans to transition its San Diego operations to the new facility to support the development of its Proteus platform and expand manufacturing capabilities.
Industry Context
StockSavvy.ai notes that this move is consistent with the broader trend of life sciences companies securing specialized laboratory and manufacturing space in key biotech hubs like San Diego to support long-term R&D and production scaling.
Comparison to Industry Standards
- The lease terms, including the tenant improvement allowance and rent abatement, are generally consistent with current market standards for high-quality life sciences facilities in the San Diego area.
- The use of a letter of credit for the security deposit is a standard practice for corporate tenants in commercial real estate.
Stakeholder Impact
- Shareholders: Long-term commitment to facility infrastructure indicates a focus on operational scaling.
- Creditors: The lease represents a significant long-term financial obligation.
Next Steps
- Completion of tenant improvements.
- Transition of operations from existing San Diego facility to the new premises by late 2027.
Key Dates
| Date | Description |
|---|---|
| 2026-06-18 | Effective Date of the Lease Agreement. |
| 2027-09-01 | Estimated Commencement Date of the lease. |
| 2027-11-01 | Outside date for lease commencement. |
| 2027-12-31 | Expiration of existing lease obligation at 5510 Morehouse, San Diego. |
| 2037-08-31 | Estimated Expiration Date of the new lease. |
Keywords
Quantum-Si, QSI, Lease Agreement, San Diego, Life Sciences, Proteus Platform, Real Estate, Manufacturing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.